7 results on '"Basbugan Y"'
Search Results
2. The effect of PDE5 inhibitors on bone and oxidative damage in ovariectomy-induced osteoporosis
- Author
-
Hamit Hakan Alp, Serkan Yildirim, Mehmet Ramazan Şekeroğlu, Levent Ediz, Yildiray Basbugan, Zübeyir Huyut, Alp, HH, Huyut, Z, Yildirim, S, Basbugan, Y, Ediz, L, Sekeroglu, MR, Sakarya Üniversitesi/Tıp Fakültesi/Temel Tıp Bilimleri Bölümü, and Şekeroğlu, Mehmet Ramazan
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Deoxypyridinoline ,Bone density ,Ovariectomy ,Osteoporosis ,Enzyme-Linked Immunosorbent Assay ,Research & Experimental Medicine ,General Biochemistry, Genetics and Molecular Biology ,Bone resorption ,Bone and Bones ,Tadalafil ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,N-terminal telopeptide ,Vardenafil Dihydrochloride ,Bone Density ,Internal medicine ,Medicine ,Animals ,Rats, Wistar ,Cyclic guanosine monophosphate ,Chromatography, High Pressure Liquid ,Original Research ,Bone mineral ,Udenafil ,Sulfonamides ,business.industry ,Phosphodiesterase 5 Inhibitors ,medicine.disease ,Disease Models, Animal ,030104 developmental biology ,Endocrinology ,Pyrimidines ,Treatment Outcome ,chemistry ,030220 oncology & carcinogenesis ,business ,Biomarkers ,medicine.drug - Abstract
Osteoporosis is a major public health problem associated with many factors, and it affects more than 50% of women over 50 years old. In the current study, our purpose was to investigate the effects of phosphodiestarase-5 inhibitors on osteoporosis via the nitric oxide/3′,5′-cyclic guanosine monophosphate/protein kinase G signalling pathway. A total of 50 female albino Wistar rats were separated into five groups. The first group was appointed as the healthy control group with no ovariectomy. All animals in the other groups underwent a bilateral ovariectomy. Six months after the ovariectomy, vardenafil, udenafil and tadalafil were given to the third, fourth and fifth groups, respectively, but were not administered to the positive control group (10 mg/kg per day for two months). The bone mineral density values were determined using a densitometry apparatus for all groups pre- and post-ovariectomy as well as after treatment. The levels of nitric oxide, endothelial nitric oxidesynthase, asymmetric dimethylarginine, 3′,5′-cyclic guanosine monophosphate, protein kinase G, phosphodiestarase-5, pyridinoline, deoxypyridinoline, carboxyterminal telopeptide fragments and plasma carboxy terminal propeptide of type I collagen were determined using an enzyme linked immunosorbent assay. The levels of malondialdehyde, 8-hydroxy-2-deoxy guanosine, deoxyguanosine and coenzyme Q10 were determined by a high-performance liquid chromatography assay. Additionally, the right femoral trabecular bone density and the epiphyseal plate were measured in all groups. Angiogenesis was histologically observed in the bone tissue. In addition, we determined that the inhibitors may have caused a positive impact on the increased bone mass density and reduction of bone resorption markers. We also observed the positive effects of these inhibitors on oxidative stress. In conclusion, these phosphodiestarase-5 inhibitors increase angiogenesis in bone tissue and improve the re-formation rate of bone in rats with osteoporosis. Chemical compounds studied in this article Udenafil (PubChem CID: 6918523); Tadalafil (PubChem CID: 110635); Vardanafil (PubCham CID: 110634). Impact statement The results in our study appear to establish the osteoporosis model and provide evidence of the positive effects of three separate PDE5 inhibitors (vardenafil, udenafil, and tadalafil). The positive effects of these PDE5 inhibitors are investigated and demonstrated by the bone mass density and bone resorption markers. These effects are associated with significant demonstrated antioxidant activities. Osteoporosis is a significant major public health problem especially in more aged populations. Advances in identifying and understanding new potential therapeutic modalities for this disease are significant. This study provides such an advance.
- Published
- 2016
3. Effects of ınjectable platelet-rich fibrin in experimental periodontitis in rats.
- Author
-
Aydinyurt HS, Sancak T, Taskin C, Basbugan Y, and Akinci L
- Subjects
- Animals, Rats, Rats, Wistar, Root Planing, Wound Healing, Periodontitis therapy, Platelet-Rich Fibrin
- Abstract
Injectable platelet-rich fibrin (i-PRF) is an effective biological material that positively contributes to angiogenesis, wound healing, inflammation, regeneration processes, etc. This research aimed to evaluate the effect of i-PRF in rats with experimental periodontitis. Following the development of ligature-induced periodontitis, 24 Wistar albino rats were divided into three groups. Group-1: scaling and root planing (only-SRP); Group-2: SRP + i-PRF; Group-3: only- i-PRF. Heart blood from six donors was used for the i-PRF application. i-PRF was administered as a subgingival injection in the relevant groups on the 1st, 3rd, and 7th days. The tissues were evaluated histopathologically and immunohistochemically. Also, bone structures were examined using micro-CT. According to the data obtained, no statistically significant difference was observed among the groups in terms of bone resorption, inflammation, bone volume, bone levels (mesial/distal), and IL-1β, IFN-ɤ, TNF-α, VEGF values (p > 0.05). However, bone mineral density was statistically significantly different among the groups (Group3 > Group2 > Group1) (p < 0.0001). Subgingival injection of only-i-PRF showed promising results in periodontitis treatment but contribution to SRP has not been proved according to this study results. The study results suggested that the i-PRF application was as effective as SRP in reducing bone loss, modulating inflammatory process, and effecting cytokines in experimental periodontitis. The significant effect of i-PRF on bone mineral density was the most remarkable result.
- Published
- 2021
- Full Text
- View/download PDF
4. Influence of some β-lactam drugs on selected antioxidant enzyme and lipid peroxidation levels in different rat tissues.
- Author
-
Türkan F, Huyut Z, Basbugan Y, and Gülçin İ
- Subjects
- Animals, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents pharmacology, Brain drug effects, Brain metabolism, Cefazolin administration & dosage, Cefoperazone administration & dosage, Cefuroxime administration & dosage, Female, Kidney drug effects, Kidney metabolism, Liver drug effects, Liver metabolism, Malondialdehyde metabolism, Rats, Rats, Wistar, Time Factors, Antioxidants metabolism, Cefazolin pharmacology, Cefoperazone pharmacology, Cefuroxime pharmacology, Lipid Peroxidation drug effects
- Abstract
Antioxidant enzymes play an important role in body defense and free radical removal. Cephalosporins are β-lactam antibiotics. In this work, the effects of cefazolin, cefuroxime and cefoperazone which are cephalosporins on some selected antioxidant enzyme and levels of malondialdehyde (MDA) as lipid peroxidation product were investigated in kidney, liver, and brain tissues of albino female rats. Ninety-six albino rats were randomly divided into 16 groups of equal number ( n = 6). 50 mg/kg cefazolin, 25 mg/kg cefuroxime, and 100 mg/kg cefoperazone were injected intraperitoneally to the groups (5th-8th and 9th-12th, and 13th-16th groups), respectively. The changes in glutathione reductase (GR), glutathione S-transferase (GST), superoxide dismutase (SOD), peroxidase (POD), and glutathione peroxidase (GSH-Px) levels were studied in each time point group and a time-dependent manner (at the 1st, 3rd, 5th and 7th hour). In addition, MDA levels were examined in all the tissues. The drugs evaluated in this study had different effects on the same enzyme in different tissues depending on time. MDA levels especially in cefazolin and cefoperazone experiments were lower in all the tissues; however, MDA levels were higher in brain and kidney tissues in the cefuroxime groups in a time-dependent manner ( p < 0.05). These results revealed the complex effects of the tested drugs on different tissues at different time points. Therefore, the dose and use of these drugs should be adjusted correctly.
- Published
- 2020
- Full Text
- View/download PDF
5. Comparison of Enalapril, Candesartan and Intralesional Triamcinolone in Reducing Hypertrophic Scar Development: An Experimental Study.
- Author
-
Demir CY, Ersoz ME, Erten R, Kocak OF, Sultanoglu Y, and Basbugan Y
- Subjects
- Administration, Oral, Analysis of Variance, Angiotensin-Converting Enzyme Inhibitors administration & dosage, Animals, Biopsy, Needle, Biphenyl Compounds, Chi-Square Distribution, Disease Models, Animal, Follow-Up Studies, Immunohistochemistry, Injections, Intralesional, Male, Rabbits, Random Allocation, Risk Assessment, Treatment Outcome, Benzimidazoles administration & dosage, Cicatrix, Hypertrophic drug therapy, Cicatrix, Hypertrophic pathology, Enalapril administration & dosage, Tetrazoles administration & dosage, Triamcinolone administration & dosage
- Abstract
Background: The purpose of this study was to compare the effects of oral enalapril, an angiotensin-converting enzyme inhibitor (ACE-I), oral candesartan, an angiotensin receptor blocker (ARB), and intralesional corticosteroid treatments in reducing scar formation., Methods: Twenty male rabbits were divided into five study groups: A (sham), B (control), C (ACE-I), D (ARB) and E (intralesional corticosteroid). The rabbit ear hypertrophic scar model was used. The hypertrophic scars were photographed and analyzed with the program ImageJ quantitatively to determine the degree of collagen fibers. The scar elevation index (SEI) was calculated at the end of the 40th day. Tissue samples were stained with hematoxylin and eosin and Masson's trichrome and examined under light microscopy for the determination of fibroblast number, epithelization, vascularization, inflammation and fibrosis., Results: The SEI was the highest in the control group with the highest number of fibroblasts under the epithelium. In the steroid group, the SEI was significantly lower than both the ACE-I (p: 0.02) and ARB (p: 0.001) groups. The density of type 1 collagen fibers was the lowest in the control group, whereas type 3 collagen fibers were highest in that group. The ACE-I and ARB groups were similar regarding densities of type 1 and type 3 collagen fibers. The density of type 1 collagen fibers was the highest in the steroid group, whereas the density of type 3 collagen fibers was the lowest in that group., Conclusions: Enalapril, candesartan and intralesional steroid therapies were all effective in reducing scar tissue development; however, enalapril and steroid groups revealed better results., No Level Assigned: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
- Published
- 2018
- Full Text
- View/download PDF
6. Paricalcitol may improve oxidative DNA damage on experimental amikacin-induced nephrotoxicity model.
- Author
-
Bulut G, Basbugan Y, Ari E, Erten R, Bektas H, Alp HH, and Bayram I
- Subjects
- 8-Hydroxy-2'-Deoxyguanosine, Animals, Anti-Bacterial Agents adverse effects, Bone Density Conservation Agents pharmacology, Deoxyguanosine analogs & derivatives, Deoxyguanosine analysis, Disease Models, Animal, Kidney metabolism, Kidney pathology, Kidney Function Tests methods, Malondialdehyde analysis, Rats, Rats, Wistar, Vascular Endothelial Growth Factor A analysis, Amikacin adverse effects, DNA Damage, Ergocalciferols pharmacology, Kidney Diseases chemically induced, Kidney Diseases diagnosis, Kidney Diseases drug therapy, Kidney Diseases metabolism, Oxidative Stress drug effects
- Abstract
This study aimed to investigate the possible protective effect of paricalcitol on experimental amikacin-induced nephrotoxicity model in rats. Wistar albino rats (n = 32) were allocated into four equal groups of eight each, the control (Group C), paricalcitol (Group P), amikacin-induced nephrotoxicity (Group A), and paricalcitol-treated amikacin-induced nephrotoxicity (Group A + P) groups. Paricalcitol was given intra-peritoneally at a dose of 0.4 μg/kg/d for 5 consecutive days prior to induction of amikacin-induced nephrotoxicity. Intra-peritoneal amikacin (1.2 g/kg) was used to induce nephrotoxicity at day 4. Renal function parameters, oxidative stress biomarkers, oxidative DNA damage (8-hydroxy-2'-deoxyguanosine/deoxyguanosine ratio), kidney histology, and vascular endothelial growth factor (VEGF) immunoexpression were determined. Group A + P had lower mean fractional sodium excretion (p < 0.001) as well as higher creatinine clearance (p = 0.026) than the amikacin group (Group A). Renal tissue malondialdehyde levels (p = 0.035) and serum 8-hydroxy-2'-deoxyguanosine/deoxyguanosine ratio (8-OHdG/dG ratio) (p < 0.001) were significantly lower; superoxide dismutase (p = 0.024) and glutathione peroxidase (p = 0.007) activities of renal tissue were significantly higher in group A + P than in group A. The mean scores of tubular necrosis (p = 0.024), proteinaceous casts (p = 0.038), medullary congestion (p = 0.035), and VEGF immunoexpression (p = 0.018) were also lower in group A + P when compared with group A. This study demonstrates the protective effect of paricalcitol in the prevention of amikacin-induced nephrotoxicity in an experimental model. Furthermore, it is the first study to demonstrate that paricalcitol improves oxidative DNA damage in an experimental acute kidney injury model.
- Published
- 2016
- Full Text
- View/download PDF
7. Investigation of the effect of the efficiency of noise at different intensities on the DNA of the newborns.
- Author
-
Ceylan N, Kaba S, Karaman K, Celiker M, Basbugan Y, and Demir N
- Subjects
- 8-Hydroxy-2'-Deoxyguanosine, Animals, Animals, Newborn, Deoxyguanosine analogs & derivatives, Deoxyguanosine blood, Hearing Loss, Noise-Induced etiology, Oxidative Stress, Rats, Time Factors, DNA Damage, Noise adverse effects
- Abstract
Hearing loss can occur in newborns exposed to high-level noise; noise exposure can cause more physiological stress and can lead to DNA damage. This study was designed to determine DNA damage in newborn rats exposed to sound at different concentrations. For this purpose, 28 newborn (3-6 days old) rats were divided into four groups of 7 rats in each group (Control and Groups of 40 decibel (dB), 70 dB, and 110 dB]. In the experimental groups, 40 dB, 70 dB, and 110 dB (7.5-15 kHz) of sound was applied to the experimental groups for 30 min a day for 7 days. DNA damage levels in the serums obtained from this study were determined by the enzyme-linked immunosorbent assay (ELISA) method. According to this, it was determined that DNA damage in the group exposed to 110 dB showed a statistically significant increase (P < 0.05) compared to the compared to the control, 40 dB, and 70 dB groups. Related to the subject, it was concluded that DNA damage may occur in newborns exposed to 110 dB or higher sound in neonatal units, wards, and home environments with newborn babies. Mothers should be warned about this situation and noise should be kept under 110 dB volume in the environments with the newborns.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.